LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: The diagnostic performance of AFP and PIVKA-II models for non-B non-C hepatocellular carcinoma

Vinh Thanh Tran / Thang Thanh Phan / Tran Bao Nguyen / Thao Thi Le / Thanh-Tram Thi Tran / Anh-Thu Thi Nguyen / Hang Thuy Nguyen / Ngoc-Diep Bui Nguyen / Toan Trong Ho / Suong Phuoc Pho / Thuy-An Thi Nguyen / Hue Thi Nguyen / Huyen Thi Mai / Bich-Tuyen Thi Pham / Khoa Dinh Nguyen / Binh Thanh Le / Thuc Tri Nguyen / Son Truong Nguyen

BMC Research Notes, Vol 16, Iss 1, Pp 1-

2023  Volume 6

Abstract: Abstract Objective This study aims to describe the diagnostic performance of alpha-fetoprotein (AFP), alpha-fetoprotein L3 isoform (AFP-L3), protein induced by vitamin K absence II (PIVKA-II), and combined biomarkers for non-B non-C hepatocellular ... ...

Abstract Abstract Objective This study aims to describe the diagnostic performance of alpha-fetoprotein (AFP), alpha-fetoprotein L3 isoform (AFP-L3), protein induced by vitamin K absence II (PIVKA-II), and combined biomarkers for non-B non-C hepatocellular carcinoma (NBNC-HCC). Results A total of 681 newly-diagnosed primary liver disease subjects (385 non-HCC, 296 HCC) who tested negativity for the hepatitis B surface antigen (HBsAg) and hepatitis C antibody (anti-HCV) enrolled in this study. At the cut-off point of 3.8 ng/mL, AFP helps to discriminate HCC from non-HCC with an area under the curve (AUC) value of 0.817 (95% confidence interval [CI]: 0.785–0.849). These values of AFP-L3 (cut-off 0.9%) and PIVKA-II (cut-off 57.7 mAU/mL) were 0.758 (95%CI: 0.725–0.791) and 0.866 (95%CI: 0.836–0.896), respectively. The Bayesian Model Averaging (BMA) statistic identified the optimal model, including patients’ age, aspartate aminotransferase, AFP, and PIVKA-II combination, which helps to classify HCC with better performance (AUC = 0.896, 95%CI: 0.872–0.920, P < 0.001). The sensitivity and specificity of the optimal model reached 81.1% (95%CI: 76.1–85.4) and 83.2% (95%CI: 78.9–86.9), respectively. Further analyses indicated that AFP and PIVKA-II markers and combined models have good-to-excellent performance detecting curative resected HCC, separating HCC from chronic hepatitis, dysplastic, and hyperplasia nodules.
Keywords AFP ; AFP-L3 ; PIVKA-II ; NBNC-HCC ; Diagnosis ; Medicine ; R ; Biology (General) ; QH301-705.5 ; Science (General) ; Q1-390
Subject code 610
Language English
Publishing date 2023-11-01T00:00:00Z
Publisher BMC
Document type Article ; Online
Database BASE - Bielefeld Academic Search Engine (life sciences selection)

More links

Kategorien

To top